AstraZeneca at EULAR, Madrid 2017

We’re pleased to be in Madrid for EULAR 2017, the annual European Congress of Rheumatology. EULAR is the primary platform for the exchange of scientific and clinical information on rheumatologic diseases in Europe and AstraZeneca will be demonstrating our commitment to advancing the understanding and treatment of these diseases.

Our research efforts are focused on gaining a better understanding of the common biology and shared molecular pathways among serious inflammatory and autoimmune diseases such as lupus, as well as the fundamental drivers and mechanisms of disease, to bring forward targeted treatments.

5 facts about lupus

The role of interferon in SLE

SLE can cause permanent cumulative organ damage

Significant challenges remain in managing lupus

Follow us on Twitter @AstraZeneca, and join the conversation #EULAR2017.

Inflammation and Autoimmunity

Developing novel treatments for a breadth of inflammatory and autoimmune diseases

Veeva ID: Z4-5156

Date of next review: June 2018